Ghrelin's second life - World Journal of Gastroenterology

33: 169-177
27 Offerhaus GJ. Gastric stump cancer: lessons from old specimens.
Lancet 1994; 343: 66-67
28 Savage A, Jones S. Histological appearances of the gastric
mucosa 15--27 years after partial gastrectomy. J Clin Pathol
1979; 32: 179-186
29 Offerhaus GJ, van de Stadt J, Huibregtse K, Tersmette AC,
Tytgat GN. The mucosa of the gastric remnant harboring
malignancy. Histologic findings in the biopsy specimens of
504 asymptomatic patients 15 to 46 years after partial gastrectomy
with emphasis on nonmalignant lesions. Cancer
1989; 64: 698-703
30 Geboes K, Rutgeerts P, Broeckaert L, Vantrappen G, Desmet
V. Histologic appearances of endoscopic gastric mucosal biopsies
10--20 years after partial gastrectomy. Ann Surg 1980;
192: 179-182
31 Farrands PA, Blake JR, Ansell ID, Cotton RE, Hardcastle JD.
Endoscopic review of patients who have had gastric surgery.
Br Med J (Clin Res Ed) 1983; 286: 755-758
32 Littler ER, Gleibermann E. Gastritis cystica polyposa. (Gastric
mucosal prolapse at gastroenterostomy site, with cystic and
infiltrative epithelial hyperplasia). Cancer 1972; 29: 205-209
33 Wu MT, Pan HB, Lai PH, Chang JM, Tsai SH, Wu CW. CT of
gastritis cystica polyposa. Abdom Imaging 1994; 19: 8-10
34 Franzin G, Novelli P. Gastritis cystica profunda. Histopathology
1981; 5: 535-547
35 Lundell L, Lindstedt G, Olbe L. Origin of gastrin liberated
by gastrin releasing peptide in man. Gut 1987; 28: 1128-1133
36 De Graef J, Keuppens F, Willems G, Woussen-Colle MC.
[Antral G cell hyperplasia in the genesis of peptic ulcer]. Gastroenterol
Clin Biol 1979; 3: 3-6
37 Domellöf L, Eriksson S, Helander HF, Janunger KG. Lipid
islands in the gastric mucosa after resection for benign ulcer
disease. Gastroenterology 1977; 72: 14-18
38 Terruzzi V, Minoli G, Butti GC, Rossini A. Gastric lipid
islands in the gastric stump and in non-operated stomach.
Endoscopy 1980; 12: 58-62
39 Oviedo J, Swan N, Farraye FA. Gastric xanthomas. Am J
Gastroenterol 2001; 96: 3216-3218
40 Khachaturian T, Dinning JP, Earnest DL. Gastric xanthelasma
in a patient after partial gastrectomy. Am J Gastroenterol
1998; 93: 1588-1589
41 Chen YS, Lin JB, Dai KS, Deng BX, Xu LZ, Lin CD, Jiang ZG.
Gastric xanthelasma. Chin Med J (Engl) 1989; 102: 639-643
42 Kimura K, Hiramoto T, Buncher CR. Gastric xanthelasma.
Arch Pathol 1969; 87: 110-117
43 Ludvíková M, Michal M, Datková D. Gastric xanthelasma
associated with diffuse signet ring carcinoma. A potential
diagnostic problem. Histopathology 1994; 25: 581-582
44 Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Tozun
N. Xanthelasmas of the upper gastrointestinal tract. J
Gastroenterol 2004; 39: 215-219
45 Toftgaard C. Gastric cancer after peptic ulcer surgery. A
historic prospective cohort investigation. Ann Surg 1989; 210:
159-164
46 Lundegårdh G, Adami HO, Helmick C, Zack M, Meirik O.
Stomach cancer after partial gastrectomy for benign ulcer
disease. N Engl J Med 1988; 319: 195-200
47 Fisher SG, Davis F, Nelson R, Weber L, Goldberg J, Haenszel
W. A cohort study of stomach cancer risk in men after gastric
surgery for benign disease. J Natl Cancer Inst 1993; 85:
1303-1310
48 Offerhaus GJ, Tersmette AC, Huibregtse K, van de Stadt J,
Tersmette KW, Stijnen T, Hoedemaeker PJ, Vandenbroucke
JP, Tytgat GN. Mortality caused by stomach cancer after remote
partial gastrectomy for benign conditions: 40 years of
follow up of an Amsterdam cohort of 2633 postgastrectomy
patients. Gut 1988; 29: 1588-1590
49 Nicholls JC. Stump cancer following gastric surgery. World J
WJG|www.wjgnet.com
Sitarz R et al . Gastroenterostoma as a premalignant condition
Surg 1979; 3: 731-736
50 El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill
S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection
and chronic gastric acid hyposecretion. Gastroenterology
1997; 113: 15-24
51 Molloy RM, Sonnenberg A. Relation between gastric cancer
and previous peptic ulcer disease. Gut 1997; 40: 247-252
52 Hansson LE, Nyrén O, Hsing AW, Bergström R, Josefsson
S, Chow WH, Fraumeni JF, Adami HO. The risk of stomach
cancer in patients with gastric or duodenal ulcer disease. N
Engl J Med 1996; 335: 242-249
53 Bahmanyar S, Ye W, Dickman PW, Nyrén O. Long-term risk
of gastric cancer by subsite in operated and unoperated patients
hospitalized for peptic ulcer. Am J Gastroenterol 2007;
102: 1185-1191
54 Tersmette AC, Goodman SN, Offerhaus GJ, Tersmette KW,
Giardiello FM, Vandenbroucke JP, Tytgat GN. Multivariate
analysis of the risk of stomach cancer after ulcer surgery in
an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol
1991; 134: 14-21
55 Saukkonen M, Sipponen P, Kekki M. The morphology and
dynamics of the gastric mucosa after partial gastrectomy.
Ann Clin Res 1981; 13: 156-158
56 Offerhaus GJ, Stadt J, Huibregtse K, Tytgat G. Endoscopic
screening for malignancy in the gastric remnant: the clinical
significance of dysplasia in gastric mucosa. J Clin Pathol 1984;
37: 748-754
57 Tytgat GN, Offerhaus JG, vd Stadt J, Huibregtse K. Early
gastric stump cancer: macroscopic and microscopic appearance.
Hepatogastroenterology 1989; 36: 103-108
58 Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW,
Smith JP, Miettinen OS. Survival of patients with stage I lung
cancer detected on CT screening. N Engl J Med 2006; 355:
1763-1771
59 Kondo K. Duodenogastric reflux and gastric stump carcinoma.
Gastric Cancer 2002; 5: 16-22
60 Watt PC, Sloan JM, Donaldson JD, Patterson CC, Kennedy
TL. Relationship between histology and gastric juice pH and
nitrite in the stomach after operation for duodenal ulcer. Gut
1984; 25: 246-252
61 Kopański Z, Brandys J, Piekoszewski W, Schlegel-Zawadzka
M, Witkowska B. The bacterial flora and the changes of the
N-nitrosamine concentration in the operated stomach. Przegl
Lek 2001; 58: 348-350
62 Yamamoto N, Tokunaga M, Uemura Y, Tanaka S, Shirahama
H, Nakamura T, Land CE, Sato E. Epstein-Barr virus and
gastric remnant cancer. Cancer 1994; 74: 805-809
63 Baas IO, van Rees BP, Musler A, Craanen ME, Tytgat GN,
van den Berg FM, Offerhaus GJ. Helicobacter pylori and
Epstein-Barr virus infection and the p53 tumour suppressor
pathway in gastric stump cancer compared with carcinoma
in the non-operated stomach. J Clin Pathol 1998; 51: 662-666
64 van Rees BP, Caspers E, zur Hausen A, van den Brule A,
Drillenburg P, Weterman MA, Offerhaus GJ. Different pattern
of allelic loss in Epstein-Barr virus-positive gastric cancer
with emphasis on the p53 tumor suppressor pathway.
Am J Pathol 2002; 161: 1207-1213
65 Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman
KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen,
binds to the retinoblastoma and p53 proteins. Proc Natl Acad
Sci USA 1993; 90: 5455-5459
66 El-Omar EM, Carrington M, Chow WH, McColl KE, Bream
JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N,
Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1
polymorphisms associated with increased risk of gastric cancer.
Nature 2000; 404: 398-402
67 El-Omar EM, Carrington M, Chow WH, McColl KE, Bream
JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman
N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. The role of
3205 July 7, 2012|Volume 18|Issue 25|